Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers C > Headlines for CytRx Corp. > News item |
CytRx files $100 million shelf covering stock, warrants, preferreds
By Devika Patel
Knoxville, Tenn., Dec. 6 - CytRx Corp. filed a $100 million shelf registration in an S-3 filing with the Securities and Exchange Commission.
The registration covers common stock, preferred stock and warrants.
The preferreds may be structured as convertibles.
Proceeds will be used to augment working capital and for general corporate purposes.
Based in Los Angeles, CytRx develops human therapeutics.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.